These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 16547245)

  • 1. Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses.
    Bihl F; Frahm N; Di Giammarino L; Sidney J; John M; Yusim K; Woodberry T; Sango K; Hewitt HS; Henry L; Linde CH; Chisholm JV; Zaman TM; Pae E; Mallal S; Walker BD; Sette A; Korber BT; Heckerman D; Brander C
    J Immunol; 2006 Apr; 176(7):4094-101. PubMed ID: 16547245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1-specific cytotoxic T lymphocyte (CTL) responses against immunodominant optimal epitopes slow the progression of AIDS in China.
    Zhai S; Zhuang Y; Song Y; Li S; Huang D; Kang W; Li X; Liao Q; Liu Y; Zhao Z; Lu Y; Sun Y
    Curr HIV Res; 2008 Jun; 6(4):335-50. PubMed ID: 18691032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunodominance among EBV-derived epitopes restricted by HLA-B27 does not correlate with epitope abundance in EBV-transformed B-lymphoblastoid cell lines.
    Crotzer VL; Christian RE; Brooks JM; Shabanowitz J; Settlage RE; Marto JA; White FM; Rickinson AB; Hunt DF; Engelhard VH
    J Immunol; 2000 Jun; 164(12):6120-9. PubMed ID: 10843661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-A11-restricted epitope polymorphism among Epstein-Barr virus strains in the highly HLA-A11-positive Chinese population: incidence and immunogenicity of variant epitope sequences.
    Midgley RS; Bell AI; Yao QY; Croom-Carter D; Hislop AD; Whitney BM; Chan AT; Johnson PJ; Rickinson AB
    J Virol; 2003 Nov; 77(21):11507-16. PubMed ID: 14557636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different immunodominance of HIV-1-specific CTL epitopes among three subtypes of HLA-A*26 associated with slow progression to AIDS.
    Kawashima Y; Satoh M; Oka S; Shirasaka T; Takiguchi M
    Biochem Biophys Res Commun; 2008 Feb; 366(3):612-6. PubMed ID: 18035044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype.
    Boon AC; de Mutsert G; Graus YM; Fouchier RA; Sintnicolaas K; Osterhaus AD; Rimmelzwaan GF
    J Virol; 2002 Jan; 76(2):582-90. PubMed ID: 11752149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-B may be more protective against HIV-1 than HLA-A because it resists negative regulatory factor (Nef) mediated down-regulation.
    Rajapaksa US; Li D; Peng YC; McMichael AJ; Dong T; Xu XN
    Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13353-8. PubMed ID: 22826228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunodominant influenza A virus M158-66 cytotoxic T lymphocyte epitope exhibits degenerate class I major histocompatibility complex restriction in humans.
    Choo JA; Liu J; Toh X; Grotenbreg GM; Ren EC
    J Virol; 2014 Sep; 88(18):10613-23. PubMed ID: 24990997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses.
    Klein MR; van der Burg SH; Hovenkamp E; Holwerda AM; Drijfhout JW; Melief CJ; Miedema F
    J Gen Virol; 1998 Sep; 79 ( Pt 9)():2191-201. PubMed ID: 9747728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained CD8+ T-cell immune response to a novel immunodominant HLA-B*0702-associated epitope derived from an Epstein-Barr virus helicase-primase-associated protein.
    Turcanová V; Höllsberg P
    J Med Virol; 2004 Apr; 72(4):635-45. PubMed ID: 14981767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation.
    Tynan FE; Elhassen D; Purcell AW; Burrows JM; Borg NA; Miles JJ; Williamson NA; Green KJ; Tellam J; Kjer-Nielsen L; McCluskey J; Rossjohn J; Burrows SR
    J Exp Med; 2005 Nov; 202(9):1249-60. PubMed ID: 16275762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential characteristics of cytotoxic T lymphocytes restricted by the protective HLA alleles B*27 and B*57 in HIV-1 infection.
    Schellens IM; Spits HB; Navis M; Westerlaken GH; Nanlohy NM; Coffeng LE; Kootstra N; Miedema F; Schuitemaker H; Borghans JA; van Baarle D
    J Acquir Immune Defic Syndr; 2014 Nov; 67(3):236-45. PubMed ID: 25171732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 allele.
    Ferrari G; Neal W; Ottinger J; Jones AM; Edwards BH; Goepfert P; Betts MR; Koup RA; Buchbinder S; McElrath MJ; Tartaglia J; Weinhold KJ
    J Immunol; 2004 Aug; 173(3):2126-33. PubMed ID: 15265949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivation of HLA-B*0702 transgenic mice: functional CTL repertoire and recognition of human B*0702-restricted CTL epitopes.
    Alexander J; Oseroff C; Sidney J; Sette A
    Hum Immunol; 2003 Feb; 64(2):211-23. PubMed ID: 12559623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control.
    Berger CT; Frahm N; Price DA; Mothe B; Ghebremichael M; Hartman KL; Henry LM; Brenchley JM; Ruff LE; Venturi V; Pereyra F; Sidney J; Sette A; Douek DC; Walker BD; Kaufmann DE; Brander C
    J Virol; 2011 Sep; 85(18):9334-45. PubMed ID: 21752903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation.
    Goulder PJ; Sewell AK; Lalloo DG; Price DA; Whelan JA; Evans J; Taylor GP; Luzzi G; Giangrande P; Phillips RE; McMichael AJ
    J Exp Med; 1997 Apr; 185(8):1423-33. PubMed ID: 9126923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic T cell recognition of allelic variants of HLA B35 bound to an Epstein-Barr virus epitope: influence of peptide conformation and TCR-peptide interaction.
    Khanna R; Silins SL; Weng Z; Gatchell D; Burrows SR; Cooper L
    Eur J Immunol; 1999 May; 29(5):1587-97. PubMed ID: 10359113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential selection pressure exerted on HIV by CTL targeting identical epitopes but restricted by distinct HLA alleles from the same HLA supertype.
    Leslie A; Price DA; Mkhize P; Bishop K; Rathod A; Day C; Crawford H; Honeyborne I; Asher TE; Luzzi G; Edwards A; Rousseau CM; Mullins JI; Tudor-Williams G; Novelli V; Brander C; Douek DC; Kiepiela P; Walker BD; Goulder PJ
    J Immunol; 2006 Oct; 177(7):4699-708. PubMed ID: 16982909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes.
    Khanna R; Burrows SR; Nicholls J; Poulsen LM
    Eur J Immunol; 1998 Feb; 28(2):451-8. PubMed ID: 9521052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.